Exchange: NASDAQ·Updated 06:30 PM EST

GNPX News

News
all
press releases
Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa Gene Therapy in Lung Cancer
Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa Gene Therapy in Lung Cancer Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa Gene Therapy in Lung CancerPR NewswireAUSTIN, Texas, Nov. 19, 2026 Data...
PR Newswire
Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa Gene Therapy in Lung Cancer
Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa Gene Therapy in Lung Cancer Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa Gene Therapy in Lung CancerPR NewswireAUSTIN, Texas, Nov. 19, 2026 Data...
PR Newswire
More News
Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy Symposium Genprex to Highlight Dual Delivery Strategy for Diabetes Gene Therapy at Future of Cell and Gene Therapy SymposiumPR NewswireAUSTIN, Texas, Nov. 11, 2026 Genprex Senior Director of...
PR Newswire
Genprex Presents Data Showing Reqorsa Gene Therapy Activates Cellular Repair and Maintenance Programs Linked to Aging Biology in Patients, Supporting TUSC2 as a Key Regulator of Resilience to Aging-Associated Stress Genprex Presents Data Showing Reqorsa Gene Therapy Activates Cellular Repair and...
PR Newswire
Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa Gene Therapy in Lung Cancer Genprex Announces New Research Identifying TROP2 as a Potential Predictive Biomarker to Reqorsa Gene Therapy in Lung CancerPR NewswireAUSTIN, Texas, Nov. 4, 2026 Research to...
PR Newswire
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America...
PR Newswire
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA, in Maintaining Cellular Function During Brain Aging Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA, in Maintaining Cellular Function During Brain AgingPR...
PR Newswire
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference PR Newswire AUSTIN, Texas, Sept. 8, 2026 Company Presentation to Highlight Lead Clinical Oncology Program and Preclinical Diabetes...
PR Newswire
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene...
PR Newswire
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies PR Newswire AUSTIN, Texas, Aug. 3, 2026 Collaboration Advances Biomarker-Driven Patient Selection and Precision...
PR Newswire
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent...
PR Newswire

Advertisement|Remove ads.